Angiotensin-converting enzyme inhibitors or calcium channel blockers? An overview

Differential gene expression of bradykinin receptors 1 and 2 in peripheral monocytes from patients with essential hypertension.

Journal of human hypertension·2014

Sympathetic overactivity in hypertension and cardiovascular disease.

Current vascular pharmacology·2013

Is 44-hour better than 24-hour ambulatory blood pressure monitoring in hemodialysis?

Kidney & blood pressure research·2006

Association between hypervolemia and ventricular hypertrophy in hemodialysis patients.

American journal of hypertension·2004

Angiotensin II as a cardiovascular risk factor.

Journal of human hypertension·2002

Role of the B(2) receptor of bradykinin in insulin sensitivity.

Hypertension (Dallas, Tex. : 1979)·2001

Atacicept: First Approval.

Drugs·2026

Pivekimab Sunirine: First Approval.

Drugs·2026

Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer's Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging Outcomes.

Drugs·2026

Vepdegestrant: First Approval.

Drugs·2026

Non-invasive Assessment and Therapeutic Targeting in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Overcoming the Dissonance Between Drug Development and Precision Medicine.

Drugs·2026

Baxdrostat: First Approval.

Drugs·2026

Bergamottin: a multitarget natural furanocoumarin with promising anticancer potential.

Translational cancer research·2026

Targeting liver angiotensinogen with siRNA enhances podocyte regeneration through renin lineage cells in experimental kidney disease.

Molecular therapy. Nucleic acids·2026

AaSnRK2.6 interacts with AaORA to positively regulate artemisinin biosynthesis in Artemisia annua.

Horticulture research·2026

Intramolecularly quenched fluorogens enable multispectral activation with a fluorescein-targeting single-chain variable fragment.

Organic & biomolecular chemistry·2026

Related Experiment Videos

Angiotensin-converting enzyme inhibitors or calcium channel blockers? An overview

Related Concept Videos

Differential gene expression of bradykinin receptors 1 and 2 in peripheral monocytes from patients with essential hypertension.

Sympathetic overactivity in hypertension and cardiovascular disease.

Is 44-hour better than 24-hour ambulatory blood pressure monitoring in hemodialysis?

Association between hypervolemia and ventricular hypertrophy in hemodialysis patients.

Angiotensin II as a cardiovascular risk factor.

Role of the B(2) receptor of bradykinin in insulin sensitivity.

Atacicept: First Approval.

Pivekimab Sunirine: First Approval.

Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer's Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging Outcomes.

Vepdegestrant: First Approval.

Non-invasive Assessment and Therapeutic Targeting in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Overcoming the Dissonance Between Drug Development and Precision Medicine.

Baxdrostat: First Approval.

Bergamottin: a multitarget natural furanocoumarin with promising anticancer potential.

Targeting liver angiotensinogen with siRNA enhances podocyte regeneration through renin lineage cells in experimental kidney disease.

AaSnRK2.6 interacts with AaORA to positively regulate artemisinin biosynthesis in Artemisia annua.

Intramolecularly quenched fluorogens enable multispectral activation with a fluorescein-targeting single-chain variable fragment.

Related Experiment Videos

Angiotensin-converting enzyme inhibitors or calcium channel blockers? An overview

Related Concept Videos

Related Articles